Categories
CURRENT TRIALS TRIAL

Suffering from  Moderate to Severe Hidradenitis Suppurativa?

Suffering from  Moderate to Severe Hidradenitis Suppurativa?

Trial – Acrotech

Incyte is conducting a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of XXXXXXXXX in Participants with Moderate to Severe Hidradenitis Suppurativa

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol #  INCB- 54707-301

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Mild to Moderate Atopic Dermatitis?

Suffering from Mild to Moderate Atopic Dermatitis?

Trial – Acrotech

Acrotech is conducting an Open-label Study to Assess the Long-Term Safety of XXXXXXXX Ointment in Mild to Moderate Atopic Dermatitis.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # MEDI-MM36-302

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Nail and Scalp Psoriasis?

Suffering from Nail and Scalp Psoriasis?

Trial – Eli Lilly

Eli Lilly is conducting a US-Based Observational Study of Nail and Scalp Psoriasis Improvement in Patients Treated with Ixekizumab (Taltz)

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol #  I1F-MC-B018

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Atopic Dermatitis with Skin of Color?

Suffering from Atopic Dermatitis with Skin of Color?

Trial – Eli Lilly

Eli Lilly is conducting an Open-Label Study of XXXXXXXXXX in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # J2T-MC-KGBP

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.